Skip to content

Oxytocin

FDA-approved context Hormonal Health 3 sources

Oxytocin is a naturally occurring neuropeptide and peptide hormone produced in the hypothalamus. It plays a crucial role in social bonding, sexual reproduction, childbirth, and the period after childbirth. Research is also exploring its potential benefits for social anxiety, autism spectrum disorder, and stress modulation.

01Dosing reference

Amount
24-40 IU (International Units) per dose for behavioral research
Frequency
Once or twice daily (intranasal)
Cycle
Used acutely before social tasks or continuously for 4-8 weeks in clinical trials
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Oxytocin Receptor Binding

Oxytocin binds to specific G-protein coupled oxytocin receptors (OXTR) located in the brain and various peripheral tissues.

02

Intracellular Signaling

Activation of OXTR triggers intracellular calcium release and activates signaling pathways like MAPK and PKC.

03

Physiological and Behavioral Effects

This leads to uterine contractions during labor, milk ejection, and modulation of neural circuits involved in social behavior and stress reduction.

03Human evidence

Intranasal oxytocin may improve social cognition and behaviors in individuals with autism spectrum disorder (ASD).

Multiple randomized controlled trials have shown mixed but promising results in enhancing emotion recognition and social interaction in ASD, though long-term efficacy remains under investigation.

Oxytocin administration can attenuate the neuroendocrine stress response.

Studies in healthy adults demonstrate that oxytocin, especially in combination with social support, reduces cortisol levels and anxiety during psychosocial stress tasks.

04Preclinical evidence

Oxytocin promotes wound healing and reduces inflammation.

Animal models show that oxytocin administration accelerates cutaneous wound healing by modulating inflammatory cytokines and promoting angiogenesis.

Oxytocin exhibits neuroprotective effects against ischemic brain injury.

Rodent models of stroke indicate that oxytocin reduces infarct volume and neuronal apoptosis, likely through its anti-inflammatory and antioxidant properties.

05What is known vs. unknown

Reasonably established
  • Crucial for labor induction and postpartum hemorrhage control in its FDA-approved intravenous/intramuscular forms.
  • Plays a fundamental role in maternal behavior, pair bonding, and social cognition.
  • Intranasal administration is the most common route in psychiatric and behavioral research to bypass the blood-brain barrier.
  • Has anxiolytic (anti-anxiety) properties and can dampen the reactivity of the amygdala to fearful stimuli.
Unknowns & limits
  • The optimal dosing and frequency for psychiatric conditions like ASD or anxiety are not well established.
  • Individual responses to oxytocin vary significantly, potentially due to genetic differences in the oxytocin receptor (OXTR) gene.
  • Long-term safety and potential desensitization of receptors with chronic intranasal use remain unclear.

06Safety & regulatory context

Regulatory statusOxytocin (Pitocin) is FDA-approved for inducing labor and controlling postpartum bleeding when administered intravenously or intramuscularly. In research and off-label contexts, intranasal oxytocin is generally considered safe and well-tolerated, with mild side effects occasionally including nasal irritation, headache, or dizziness. However, its use for psychiatric or behavioral conditions is not FDA-approved. Contraindications for systemic use include fetal distress or abnormal fetal presentation during labor.

07Compared with Vasopressin

Oxytocin vs. Vasopressin
Key difference
While oxytocin is primarily associated with social bonding, relaxation, and maternal functions, vasopressin is more closely linked to water retention, blood pressure regulation, and aggressive or territorial behaviors, despite both being nonapeptides with similar structures.
When researchers discuss each
Researchers discuss oxytocin when focusing on prosocial behavior, trust, and childbirth, whereas vasopressin is discussed in the context of cardiovascular regulation, fluid balance, and male-typical social behaviors.

08Glossary

Neuropeptide
A small protein-like molecule used by neurons to communicate with each other.
Hypothalamus
A region of the brain that controls many fundamental functions, including hormone release, temperature regulation, and emotional responses.
Intranasal
Administration of a drug or compound through the nasal cavity, often used to target the brain more directly.

09Knowledge check

Q1Which of the following is an FDA-approved use for oxytocin?
Q2Why is oxytocin often administered intranasally in behavioral research?
Q3Which documented limitation in the dossier helps explain why results from intranasal oxytocin studies for psychiatric conditions can vary between participants?
Q4According to the dossier's stated comparison, in which research contexts is vasopressin discussed more than oxytocin?
Q5Which statement best reflects the dossier's safety and regulatory context for oxytocin?

10Sources

More in Hormonal Health

See all
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.